Mirati Therapeutics logo
Mirati Therapeutics MRTX
$ 58.7 0.0%

Quarterly report 2023-Q3
added 11-06-2023

report update icon

Mirati Therapeutics Interest Expense 2011-2024 | MRTX

Annual Interest Expense Mirati Therapeutics

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
19.2 M -5.3 M 11.4 M 8.85 M 4.21 M 1.1 M 661 K 170 K -77 K -1.08 M 251 K -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
19.2 M -5.3 M 3.58 M

Quarterly Interest Expense Mirati Therapeutics

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
10.2 M 10.4 M 9.24 M - 13.1 M 760 K -4.17 M - 2.74 M -2.24 M -3.26 M - 1.34 M 2 M 2.83 M - 2.79 M 1.95 M 1.85 M - 1.37 M 801 K 637 K - 251 K 277 K 244 K - 160 K 166 K 204 K - -17 K 70 K 46 K - 24 K 73 K -202 K - 462 K -694 K -570 K - 34 K 70 K - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
13.1 M -4.17 M 1.51 M